This Plain Language Summary of Publication article (PLSP) from Current Medical Research & Opinion describes how researchers analyzed brexpiprazole’s side effects in Alzheimer’s dementia patients with agitation. Since medications can cause harmful effects in older dementia patients, they combined data from four clinical studies to examine brexpiprazole’s safety profile over 3 and 6 months of treatment for agitation symptoms like restlessness, wandering, and shouting.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer’s Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial’ and was published in CNS Drug.

Visit Springer Nature using the link to read the original article.